跳至主要内容
临床试验/NCT05130762
NCT05130762已完成不适用

A Post-Market Clinical Follow Up Study to Evaluate BD PureHub™ Disinfecting Cap Use on Needle-Free Connectors

Becton, Dickinson and Company5 个研究点 分布在 4 个国家目标入组 157 人开始时间: 2022年1月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
157
试验地点
5
主要终点
Attachment & Removal Success Rate of the BD PureHub Disinfecting Caps to a Needle-free Connector

研究概览

简要总结

The study will collect use data of the Becton Dickinson (BD) PureHub™ Disinfecting Cap in combination with needle-free connectors, which are attached to vascular access devices (VAD).

详细描述

This is a multi-center, prospective observational study of a minimum of 150 study participants who have vascular access devices (VADs) with needle-free connectors as part of their routine medical care.

Patients will be followed from the time of enrollment through the duration of VAD therapy or 45 days post enrollment date, whichever comes first.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Has an eligible vascular access device with needle-free connectors in situ or will have one placed Note: This covers all needle-free devices, including central venous catheters, peripheral IV catheters and arterial VADs
  • Is expected to receive VAD therapy for a minimum of 3 days
  • Is expected to be available for regular observation from consent until end of study
  • Able and willing to provide informed consent or legal authorized representative (LAR) authorized to give consent on behalf of the participant

排除标准

  • BD PureHub™ Disinfecting Cap or any other disinfecting cap in place for more than twelve (12) hours (>12 hours) prior to study participation
  • Presence of any infection, bacteremia, or septicemia is known or suspected
  • Any condition which, in the opinion of the Investigator, precludes the participant from participation in this study

结局指标

主要结局

Attachment & Removal Success Rate of the BD PureHub Disinfecting Caps to a Needle-free Connector

时间窗: Up to 45 days post-enrollment date

* Attachment success rate of the BD PureHub™ Disinfecting Caps to a needle-free connector (successful attachment/total number of attachments) * Removal success rate of the BD PureHub™ Disinfecting Caps to a needle-free connector (successful removal/ total number of intended removals)

Number of Participants With BD PureHub™ Disinfecting Cap Device-related Adverse Events.

时间窗: Up to 45 days post-enrollment date

Rate of device-related adverse events

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验